Literature DB >> 12443670

Low mortality after mild measles infection compared to uninfected children in rural West Africa.

Peter Aaby1, Francois Simondon, Badara Samb, Badara Cisse, Henrik Jensen, Ida Maria Lisse, Masserigne Soumaré, Hilton Whittle.   

Abstract

BACKGROUND: It has been assumed that measles infection may be associated with persistent immune suppression and long-term excess mortality. However, few community studies of mortality after measles infection have been carried out. We examined long-term mortality for measles cases, sub-clinical measles cases, and uninfected contacts after an epidemic in rural Senegal.
METHODS: The study was carried out in Niakhar, a rural area of Senegal. Index cases of measles were identified and children less than 7 years of age exposed to measles in the same compound had acute and convalescent blood samples collected. Clinically diagnosed measles cases were serologically confirmed. Children without clinical symptoms were classified as sub-clinical cases if they had a four-fold or greater change in antibody levels between samples collected at exposure and 1 month later and as uninfected if there was no or a two-fold change in antibody levels.
RESULTS: There were 31 index cases, and among 184 exposed contacts, 35 (19%) children developed clinical measles. Among contacts that did not develop clinical measles, 45% had sub-clinical infection. Measles cases, sub-clinical cases, and uninfected contacts did not differ with respect to nutritional status. However, uninfected children without clinical symptoms and change in antibody level had higher initial measles specific IgG antibody levels and less intensive exposure to the index case. No index or secondary case of measles died in the acute phase of infection nor did any of the children exposed to measles die in the first 2 months after exposure. Exposed children developing clinical measles had lower age-adjusted mortality over the next 4 years than exposed children who did not develop clinical measles (P<0.05). Sub-clinical measles cases tended to have low mortality and compared with uninfected children, exposed children with clinical or sub-clinical measles had lower age-adjusted mortality (mortality ratio (MR)=0.20 (0.06-0.74)). Controlling for background factors had no impact of the estimates.
CONCLUSIONS: When measles infection is mild, clinical measles has no long-term excess mortality and may be associated with better overall survival than no clinical measles infection. Sub-clinical measles is common among immunised children and is not associated with excess mortality.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12443670     DOI: 10.1016/s0264-410x(02)00430-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Effect of early two-dose measles vaccination on childhood mortality and modification by maternal measles antibody in Guinea-Bissau, West Africa: A single-centre open-label randomised controlled trial.

Authors:  Sebastian Nielsen; Ane B Fisker; Isaquel da Silva; Stine Byberg; Sofie Biering-Sørensen; Carlitos Balé; Amarildo Barbosa; Morten Bjerregaard-Andersen; Nadja Skadkær Hansen; Vu An Do; Ole Bæk; Stine Møller Rasmussen; Lone Damkjær; Sophus Hvidt; Olga Baltzersen; Amabelia Rodrigues; Cesario Martins; Kristoffer J Jensen; Hilton C Whittle; Gaby Smits; Fiona van der Klis; Peter Aaby; Christine S Benn
Journal:  EClinicalMedicine       Date:  2022-05-27

2.  Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Carlito Balé; Andreas Andersen; Amabelia Rodrigues; Henrik Ravn; Ida M Lisse; Christine S Benn; Hilton C Whittle
Journal:  BMJ       Date:  2010-11-30

3.  Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries.

Authors:  Peter Aaby; Christine Benn; Jens Nielsen; Ida Maria Lisse; Amabelia Rodrigues; Henrik Ravn
Journal:  BMJ Open       Date:  2012-05-22       Impact factor: 2.692

4.  Introduction of standard measles vaccination in an urban African community in 1979 and overall child survival: a reanalysis of data from a cohort study.

Authors:  Søren Wengel Mogensen; Peter Aaby; Lars Smedman; Cesário L Martins; Amabelia Rodrigues; Christine S Benn; Henrik Ravn
Journal:  BMJ Open       Date:  2016-12-20       Impact factor: 2.692

5.  Measles Vaccination Supports Millennium Development Goal 4: Increasing Coverage and Increasing Child Survival in Northern Ghana, 1996-2012.

Authors:  Paul Welaga; Abraham Hodgson; Cornelius Debpuur; Peter Aaby; Fred Binka; Daniel Azongo; Abraham Oduro
Journal:  Front Public Health       Date:  2018-02-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.